Status:
UNKNOWN
Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study
Lead Sponsor:
Sheba Medical Center
Conditions:
Infants With Positive GBS Bacteremia
Eligibility:
All Genders
Up to 2 years
Brief Summary
Streptococci group B (GBS) is a the major reason for morbidity and mortality in neonates. It can present as pneumonia ,meningitis or sepsis.The mortality today is 5-20% and even more in preterm babies...
Detailed Description
This is a retrospective case control study. We will review from archive the charts of all the neonates with positive blood culture for GBS, reviewing the course and severity of their illness.
Eligibility Criteria
Inclusion
- GBS positive blood culture neonate and preterm babies
Exclusion
- Congenital malformations
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00326313
Start Date
June 1 2006
Last Update
May 16 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.